226 related articles for article (PubMed ID: 29274374)
1. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
[TBL] [Abstract][Full Text] [Related]
2. Nanobody-photosensitizer conjugates for targeted photodynamic therapy.
Heukers R; van Bergen en Henegouwen PM; Oliveira S
Nanomedicine; 2014 Oct; 10(7):1441-51. PubMed ID: 24394212
[TBL] [Abstract][Full Text] [Related]
3. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells.
De Groof TWM; Mashayekhi V; Fan TS; Bergkamp ND; Sastre Toraño J; van Senten JR; Heukers R; Smit MJ; Oliveira S
Mol Pharm; 2019 Jul; 16(7):3145-3156. PubMed ID: 31244224
[TBL] [Abstract][Full Text] [Related]
5. Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine.
Pille J; van Lith SA; van Hest JC; Leenders WP
Biomacromolecules; 2017 Apr; 18(4):1302-1310. PubMed ID: 28269985
[TBL] [Abstract][Full Text] [Related]
6. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
[TBL] [Abstract][Full Text] [Related]
7. A Conjugate of an Anti-Epidermal Growth Factor Receptor (EGFR) VHH and a Cell-Penetrating Peptide Drives Receptor Internalization and Blocks EGFR Activation.
van Lith SAM; van den Brand D; Wallbrecher R; van Duijnhoven SMJ; Brock R; Leenders WPJ
Chembiochem; 2017 Dec; 18(24):2390-2394. PubMed ID: 28994180
[TBL] [Abstract][Full Text] [Related]
8. VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells.
Heukers R; Mashayekhi V; Ramirez-Escudero M; de Haard H; Verrips TC; van Bergen En Henegouwen PMP; Oliveira S
Antibodies (Basel); 2019 Apr; 8(2):. PubMed ID: 31544832
[TBL] [Abstract][Full Text] [Related]
9. Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.
de Bruijn HS; Mashayekhi V; Schreurs TJL; van Driel PBAA; Strijkers GJ; van Diest PJ; Lowik CWGM; Seynhaeve ALB; Hagen TLMT; Prompers JJ; Henegouwen PMPVBE; Robinson DJ; Oliveira S
Theranostics; 2020; 10(5):2436-2452. PubMed ID: 32089747
[TBL] [Abstract][Full Text] [Related]
10. Detection and Specific Elimination of EGFR
Bauerschlag D; Meinhold-Heerlein I; Maass N; Bleilevens A; Bräutigam K; Al Rawashdeh W; Di Fiore S; Haugg AM; Gremse F; Steitz J; Fischer R; Stickeler E; Barth S; Hussain AF
Pharm Res; 2017 Apr; 34(4):696-703. PubMed ID: 28074431
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome.
Park CK; Kim YH; Hwangbo S; Cho H
Int J Nanomedicine; 2017; 12():8185-8196. PubMed ID: 29184407
[TBL] [Abstract][Full Text] [Related]
12. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD
Cancer Res; 2005 Jul; 65(14):6371-9. PubMed ID: 16024640
[TBL] [Abstract][Full Text] [Related]
13. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S
Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290
[No Abstract] [Full Text] [Related]
14. In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.
Beltrán Hernández I; De Groof TWM; Heukers R; Oliveira S
Methods Mol Biol; 2022; 2451():505-520. PubMed ID: 35505028
[TBL] [Abstract][Full Text] [Related]
15. Endosomal Escape of Peptide-Photosensitizer Conjugates Is Affected by Amino Acid Sequences near the Photosensitizer.
Miyoshi Y; Kadono M; Okazaki S; Nishimura A; Kitamatsu M; Watanabe K; Ohtsuki T
Bioconjug Chem; 2020 Mar; 31(3):916-922. PubMed ID: 32027488
[TBL] [Abstract][Full Text] [Related]
16. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
[TBL] [Abstract][Full Text] [Related]
17. Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates.
van Lith SA; van Duijnhoven SM; Navis AC; Leenders WP; Dolk E; Wennink JW; van Nostrum CF; van Hest JC
Bioconjug Chem; 2017 Feb; 28(2):539-548. PubMed ID: 28045502
[TBL] [Abstract][Full Text] [Related]
18. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
Amoury M; Bauerschlag D; Zeppernick F; von Felbert V; Berges N; Di Fiore S; Mintert I; Bleilevens A; Maass N; Bräutigam K; Meinhold-Heerlein I; Stickeler E; Barth S; Fischer R; Hussain AF
Oncotarget; 2016 Aug; 7(34):54925-54936. PubMed ID: 27448975
[TBL] [Abstract][Full Text] [Related]
19. Photoimmunotherapy Using Cationic and Anionic Photosensitizer-Antibody Conjugates against HIV Env-Expressing Cells.
Sadraeian M; Bahou C; da Cruz EF; Janini LMR; Sobhie Diaz R; Boyle RW; Chudasama V; Eduardo Gontijo Guimarães F
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271741
[TBL] [Abstract][Full Text] [Related]
20. Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors.
Renard E; Collado Camps E; Canovas C; Kip A; Gotthardt M; Rijpkema M; Denat F; Goncalves V; van Lith SAM
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
